Clinuvel Pharmaceuticals (OTCMKTS:CLVLY) and Achilles Therapeutics plc American Depositary Shares (NASDAQ:ACHL) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, dividends, valuation, institutional ownership, profitability and risk.
Analyst Ratings
This is a summary of current ratings for Clinuvel Pharmaceuticals and Achilles Therapeutics plc American Depositary Shares, as provided by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score |
---|
Clinuvel Pharmaceuticals | 0 | 0 | 1 | 0 | 3.00 |
Achilles Therapeutics plc American Depositary Shares | 0 | 0 | 0 | 0 | N/A |
Profitability
This table compares Clinuvel Pharmaceuticals and Achilles Therapeutics plc American Depositary Shares' net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets |
---|
Clinuvel Pharmaceuticals | N/A | N/A | N/A |
Achilles Therapeutics plc American Depositary Shares | N/A | N/A | N/A |
Valuation and Earnings
This table compares Clinuvel Pharmaceuticals and Achilles Therapeutics plc American Depositary Shares' revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio |
---|
Clinuvel Pharmaceuticals | N/A | N/A | N/A | N/A | N/A |
Achilles Therapeutics plc American Depositary Shares | N/A | N/A | N/A | N/A | N/A |
Summary
Clinuvel Pharmaceuticals beats Achilles Therapeutics plc American Depositary Shares on 1 of the 1 factors compared between the two stocks.